Back to News
Feb 26, 2026 8:01 AM

BioCryst Pharma: Q4 Earnings Insights

BioCryst Pharma (NASDAQ:BCRX) announced its Q4 earnings on Thursday, February 26, 2026 at 07:00 AM.

Here's a breakdown of the earnings report.

Earnings

BioCryst Pharma missed estimated earnings by -21.43%, reporting an EPS of $0.055 versus an estimate of $0.07.

Revenue was up $31.75 million from the same period last year.

Past Earnings Performance

In the previous quarter, the company beat on ...